CIK: 0001232621 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value ($000): $680,444 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 12,412,338 | $262,893 | 38.6% | $24.94 | — | COM | 676079106 |
| HRTX | HERON THERAPEUTICS INC | 8,648,252 | $238,692 | 35.1% | $14.10 | +60.9% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 4,138,893 | $123,256 | 18.1% | $18.53 | — | COM | 503459604 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $55,603 | 8.2% | $16.31 | 0.0% | COM | 77313F106 |